Frontlight ResearchEarly access
Trial site
Indago Research & Health Center, Inc
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Type 2 diabetes3 trials
- Alzheimer disease1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Pfizer1 trial
Running trials
Not yet recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Type 2 diabetes2 recruiting
- Alzheimer disease1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026